jilibay live
jilibay live
New York Jets (4-11) at Buffalo (12-3) Sunday, 1 p.m. EST, CBS BetMGM NFL odds: Bills by 9 1/2. Series record: Bills lead 70-58. Against the spread: Jets 5-10, Bills 9-6. Last meeting: Bills beat Jets 23-20 on Oct. 14, at East Rutherford, New Jersey. Last week: Jets lost to Rams 19-9; Bills beat Patriots 24-21. Jets offense: overall (23), rush (31), pass (17), scoring (24). Jets defense: overall (4), rush (16), pass (5), scoring (16). Bills offense: overall (7), rush (9), pass (9), scoring (2). Bills defense: overall (23), rush (14), pass (25), scoring (11). Turnover differential: Jets minus-2; Bills plus-20. QB Aaron Rodgers. The 41-year-old four-time NFL MVP is one touchdown pass from joining Tom Brady (649), Drew Brees (571), Peyton Manning (539) and Brett Favre (508) as the only players to throw 500 in the regular season. He’s dealing with a knee injury that he described as “a little MCL,” but insisted early in the week he’d play and was off the injury report on Friday. Rodgers could be playing in the last two games of his storied career as he’s undecided if he wants to return for a 21st year, and his future with the Jets uncertain as the team searches for a new general manager and head coach. RB James Cook. The third-year player has topped 100 yards rushing in three of his past four, and scored five TDs, including one receiving, over that span. His 14 TDs rushing are tied for first in the NFL entering Thursday, and rank third on the Bills single-season list, behind Josh Allen, who scored 15 last year, and O.J. Simpson (16, 1975). Bills pass rush vs. Jets O-line. The Bills, who rely mostly on a four-man pass rush, rank 25th in the NFL in by averaging 6.59% sacks per pass attempt. They face a veteran quarterback in Rodgers and a line that will be without starting left tackle after rookie Olu Fashanu (left foot) landed on IR this week. Max Mitchell and Carter Warren were competing this week to replace him. Jets K Greg Zuerlein was being activated from injured reserve after missing seven games with a knee injury. ... WR Davante Adams (hip) was questionable, but optimistic about playing. ... DT Quinnen Williams sat out last week with a hamstring injury, but could return to play at Buffalo. ... CB Sauce Gardner (hamstring) was questionable, as were RT Morgan Moses (knee), S Tony Adams (ankle), CB Michael Carter II (back) and DE Haason Reddick (neck). ... The Bills are getting healthier with starting CB Rasul Douglas practicing fully after missing two games. ... Buffalo’s starting safety tandem of Damar Hamlin (rib) and Taylor Rapp (neck) were questionable after practicing on a limited basis all week after also missing the past two outings. ... Starting LB Matt Milano was off the injury report after missing last weekend with groin injury. ... Allen was listed as a full participant all week after hurting his throwing elbow and shoulder against New England. The teams have split the past two season series, with the Jets being the Bills only division rival to have beaten them once in each of the past two seasons. ... The Bills have won four straight at home since a 13-6 loss in a mean-nothing 2019 season finale in which Buffalo rested a majority of its starters after the first quarter. ... Buffalo is 16-8 in the past 24 meetings since snapping a six-game skid spanning the 2009-12 seasons. The Jets are 2-8 since defensive coordinator Jeff Ulbrich replaced the fired Robert Saleh on Oct. 8 on an interim basis. ... Rodgers is interception-free in seven of his past eight games, including none in each of the Jets’ past four on the road. ... Rodgers needs one TD pass to give him 25 for the season. It would be the 14th time in his 20-year career he reached the mark, tying him with Brees (14) for the third-most seasons with at least that many. Only Brady (17) and Manning (16) have more. ... Rodgers and WR Davante Adams have connected for 82 touchdowns, including the postseason, to tie Miami’s Dan Marino and Mark Clayton for the third most in NFL history by a quarterback-wide receiver duo. ... Adams needs 72 yards receiving for his sixth 1,000-yard season. ... In nine games since being acquired from Las Vegas, Adams has 56 catches for 719 yards and six TDs. ... WR Garrett Wilson needs 13 yards receiving to reach 1,000 for the third straight season to start his career. He’s six catches away from surpassing his career high of 95 set last season. ... The Jets went 99 yards on their opening possession to score a touchdown for the second straight game on their first drive after not doing so previously all season. ... New York scored nine points and had no punts in the loss to Los Angeles. The Jets joined the 1991 Colts — a 16-7 loss to the Patriots in the season opener — as the only teams in the Super Bowl era to score fewer than 10 points and not punt. ... The Jets allowed 110 net passing yards against the Rams, the third fewest they’ve given up this season and fifth time they held an opponent under 150 this season. ... The Bills are a win from clinching the AFC’s No. 2 seed entering the playoffs. ... Buffalo has 12 wins for just the seventh time in team history, and third since 2020, and in position to match the team record previously done four times (1990, 1991, 2020 and 2022). ... The Bills are 10-0 at home since a 24-22 loss to Denver on Nov. 13, 2023, and have an opportunity to finish a season without a home loss for just the second time in team history (8-0 in 1990). ... Allen’s 75 wins through his first seven NFL seasons are tied for the most with Russell Wilson. ... Allen, who threw just his sixth interception of the season last week and also has two lost fumbles, is 6-1 this season and 44-27 overall when committing turnover. ... Buffalo’s 29 TDs rushing match a single-season team record set in 2016. ... Buffalo is 4-3 this season when trailing at the half after overcoming a 14-7 deficit against New England. ... Buffalo improved to 28-22 when allowing 20 or more points since 2019. The team went a combined 12-67 when allowing that many from 2011-18. ... Buffalo forced three turnovers last week, and has a takeaway in all but one outing this season. Allen might have gotten you to your championship weekend, but he could be hard-pressed to put up big numbers against the Jets. Allen is 3-2 in his past five meetings and averaging just 215 yards passing, with seven touchdowns and six interceptions while being sacked 16 times. AP NFL: https://apnews.com/hub/NFLTrump returning to Project 2025 authors after rejecting their work on the trail
Eagles QB Kenny Pickett expects to be ‘ready to go’ vs. CowboysFlutterwave, Africa’s leading payments technology company, has announced that its Founder and CEO, Olugbenga ‘GB’ Agboola, has been appointed to the advisory board of the Smithsonian’s National Museum of African Art. This appointment reflects Flutterwave’s continued commitment to supporting and celebrating African excellence across various sectors on the continent and beyond. The National Museum of African Art, the only U.S. museum devoted to the art of Africa, selected Agboola as one of seven new board members during its 60th anniversary year. This appointment places the Flutterwave Founder and CEO alongside leaders in academia, healthcare, and finance who will help shape the museum’s future direction. “It is a privilege to work with each of these new board members,” said John K. Lapiana, the museum’s director. “Our museum will benefit immeasurably from their perspectives and insight, especially now during our 60th anniversary year.” As a technology leader who has consistently worked to showcase African innovation on the global stage, Mr. Agboola brings unique insights to the museum’s mission of promoting cross-cultural understanding. His appointment creates an exciting bridge between Africa’s digital transformation and its rich cultural heritage. “It is an honour to support the National Museum of African Art in its mission to bring Africa’s vibrant heritage to a global audience. Olugbenga “GB” Agboola, Founder and CEO of Flutterwave and member of Smithsonian’s National Museum of African Art Board commented. “This opportunity aligns with Flutterwave’s vision of building solutions and contributing to opportunities that showcase Africa’s talent, potential, and innovation. I look forward to collaborating with the museum to highlight the connection between Africa’s cultural history and its future in the digital age,” Agboola added in a statement. The National Museum of African Art’s collection includes over 13,000 artworks spanning more than 1,000 years of African history. As a board member, the Flutterwave founder and CEO will contribute to the museum’s efforts to showcase Africa’s artistic achievements to a global audience. Agboola also represents Flutterwave, as an inaugural member of the Milken Institute’s Africa Leaders Business Council. He serves on the boards of several prestigious organisations, like the U.S.-Africa Business Centre of the U.S. Chamber of Commerce, and the Corporate Council on Africa. Flutterwave has been recognised in Africa and globally for its payment innovations and role as an ecosystem enabler. The company was named Fast Company’s Most Innovative Company for Europe, the Middle East, and Africa in 2024. Flutterwave remains committed to supporting initiatives that celebrate African excellence in all its forms from technology to art.
Pacific Biosciences of California, Inc. ( NASDAQ:PACB – Get Free Report )’s share price gapped down before the market opened on Thursday . The stock had previously closed at $1.95, but opened at $1.90. Pacific Biosciences of California shares last traded at $1.87, with a volume of 564,827 shares trading hands. Wall Street Analysts Forecast Growth PACB has been the subject of a number of recent research reports. UBS Group cut shares of Pacific Biosciences of California from a “buy” rating to a “neutral” rating and set a $2.00 price objective for the company. in a research note on Monday, November 11th. Piper Sandler lifted their price target on Pacific Biosciences of California from $2.00 to $2.50 and gave the stock a “neutral” rating in a research report on Monday, November 11th. Scotiabank decreased their price objective on Pacific Biosciences of California from $7.00 to $6.00 and set a “sector outperform” rating on the stock in a research report on Monday, November 11th. Finally, StockNews.com upgraded Pacific Biosciences of California to a “sell” rating in a report on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $2.95. Read Our Latest Analysis on PACB Pacific Biosciences of California Price Performance Institutional Inflows and Outflows Hedge funds and other institutional investors have recently bought and sold shares of the company. Carret Asset Management LLC lifted its position in shares of Pacific Biosciences of California by 142.5% in the 2nd quarter. Carret Asset Management LLC now owns 77,600 shares of the biotechnology company’s stock worth $106,000 after purchasing an additional 45,600 shares during the period. Rhumbline Advisers lifted its stake in shares of Pacific Biosciences of California by 13.4% during the 2nd quarter. Rhumbline Advisers now owns 436,868 shares of the biotechnology company’s stock worth $598,000 after purchasing an additional 51,727 shares during the last quarter. Impact Partnership Wealth LLC bought a new stake in Pacific Biosciences of California during the second quarter valued at about $37,000. Koss Olinger Consulting LLC purchased a new position in Pacific Biosciences of California in the second quarter valued at about $1,096,000. Finally, Daiwa Securities Group Inc. lifted its position in shares of Pacific Biosciences of California by 4.2% during the second quarter. Daiwa Securities Group Inc. now owns 235,308 shares of the biotechnology company’s stock valued at $322,000 after buying an additional 9,516 shares during the last quarter. About Pacific Biosciences of California ( Get Free Report ) Pacific Biosciences of California, Inc designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. Featured Articles Receive News & Ratings for Pacific Biosciences of California Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pacific Biosciences of California and related companies with MarketBeat.com's FREE daily email newsletter .